文献速递前列腺癌前列腺增生与排尿功能障碍

机器人辅助重建治疗难治性膀胱尿道吻合口狭窄的持久疗效:TURNS研究

Durable Treatment of Refractory Vesicourethral Anastomotic Stenosis via Robotic-assisted Reconstruction: A Trauma and Urologic Reconstructive Network of Surgeons Study.
PubMed 文献 · Eur Urol · 2021-09-11

本研究纳入2015至2020年TURNS联盟中32例前列腺癌根治术后难治性膀胱尿道吻合口狭窄(VUAS)患者,行机器人辅助重建,中位随访12个月。结果显示75%患者修复通畅,81%可经尿道排尿,无预先尿失禁者中85%保持控尿,无患者需尿流改道。

要点

  • 机器人辅助VUAS重建对难治性狭窄可行,中位随访12月通畅率75%。
  • 81%患者术后可经尿道排尿,无预先SUI者85%维持控尿。
  • 无患者需尿流改道,30天并发症多可保守处理。

核心结论

  • 机器人辅助VUAS重建是前列腺癌根治术后难治性吻合口狭窄可行且成功的治疗选择,经腹机器人入路显示高通畅率和控尿率。

研究设计与样本

  • 多中心 consortium 研究,纳入2015至2020年TURNS联盟机构中32例VUAS行机器人辅助重建患者,术后最低随访3个月。

主要发现

  • 32例中16例(50%)有盆腔放疗史,15例(47%)为闭塞性VUAS,中位住院时间1天。
  • 中位随访12个月时,24例(75%)修复通畅,26例(81%)经尿道排尿。
  • 5例发生30天并发症,其中4例保守处理(导管梗阻和肠梗阻);8例复发狭窄经再次机器人重建(2例)、内镜(4例)或导尿(2例)处理。
  • 13例无预先SUI患者中,11例(85%)末次随访时保持控尿;无患者行尿流改道。

关键数值与推荐

  • 通畅定义为可通过17 French软性膀胱镜或尿流率峰值>15 ml/s。
  • 新发SUI定义为每日使用超过1个尿垫或需手术干预。

临床怎么用

  • 对前列腺癌根治术后难治性VUAS,可考虑机器人辅助重建以恢复尿道通畅并保留控尿。
  • 术后需监测复发狭窄,复发者可选择再次机器人重建、内镜或导尿处理。

局限性

  • 样本量较小(32例),随访时间有限(中位12个月),部分患者有盆腔放疗史可能影响结果普适性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Refractory vesicourethral anastomotic stenosis (VUAS) after radical prostatectomy poses challenges distinct from bladder neck contracture, due to close proximity to the sphincter mechanism. Open reconstruction is technically demanding, risking de novo stress urinary incontinence (SUI) or recurrence. OBJECTIVE: To demonstrate patency and continence outcomes of robotic-assisted VUAS repair. DESIGN, SETTING AND PARTICIPANTS: Patients with VUAS underwent robotic-assisted reconstruction from 2015 to 2020 in the Trauma and Urologic Reconstructive Network of Surgeons (TURNS) consortium of institutions. The minimum postoperative follow-up was 3 mo. SURGICAL PROCEDURE: The space of Retzius is dissected and fibrotic tissue at the vesicourethral anastomosis is excised. Reconstruction is performed with either a primary anastomotic or an anterior bladder flap-based technique. MEASUREMENTS: Patency was defined as either the passage of a 17 French flexible cystoscope or a peak flow on uroflowmetry of >15 ml/s. De novo SUI was defined as either more than one pad per day or need for operative intervention. RESULTS AND LIMITATIONS: A total of 32 patients met the criteria, of whom 16 (50%) had a history of pelvic radiation. Intraoperatively, 15 (47%) patients had obliterative VUAS. The median length of hospital stay was 1 d. At a median follow-up of 12 mo, 24 (75%) patients had patent repairs and 26 (81%) were voiding per urethra. Of five men with 30-d complications, four were resolved conservatively (catheter obstruction and ileus). In eight patients, recurrent stenoses were managed with redo robotic reconstruction (in two), endoscopically (in four), or catheterization (in two). Of 13 patients without preexisting SUI, 11 (85%) remained continent at last follow-up. No patients underwent urinary diversion. CONCLUSIONS: Robotic-assisted VUAS reconstruction is a viable and successful management option for refractory anastomotic stenosis following radical prostatectomy. The robotic transabdominal approach demonstrates high patency and continence rates. PATIENT SUMMARY: We studied the outcomes of robotic-assisted repair for vesicourethral anastomotic stenosis. Most patients, after the procedure, were able to void per urethra and preserve existing continence.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Shakir NA, Alsikafi NF, Buesser JF, et al. Durable Treatment of Refractory Vesicourethral Anastomotic Stenosis via Robotic-assisted Reconstruction: A Trauma and Urologic Reconstructive Network of Surgeons Study. Eur Urol. 2021. PMID: 34521553. doi:10.1016/j.eururo.2021.08.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。